Allieva Pharma pvt ltd participated in Oncology 2026 conference in Kochi, showcasing its oncology medicines and commitment to affordable cancer care solutions
By Chandan Kumar | March 14, 2026
Allieva Pharma Private Limited proudly participated in Oncology 2026, an international medical conference focused on the multidisciplinary management of common cancers. Organized by the Cancer Control & Research Society, the event was held in Kochi and brought together leading oncologists, healthcare professionals, researchers, and pharmaceutical companies from across India and abroad.
At the conference, Allieva Pharma presented its vision of “The Future of Affordable Cancer Care.” The company showcased its growing portfolio of oncology medicines, including tablets, capsules, and injectable therapies designed to support modern cancer treatment.
The exhibition booth attracted many doctors, oncology specialists, and healthcare professionals who visited to learn more about the company's oncology product range and pharmaceutical innovations.
During the event, Allieva Pharma highlighted several oncology products developed to support the treatment of different types of cancer. These medicines are manufactured following strict quality standards to ensure safety, reliability, and effectiveness.
Visitors to the booth explored:
➢ Oncology tablets and capsules
➢ Oncology injectable medicines
➢ Advanced cancer therapy solutions
➢ Affordable oncology treatment options
Medical conferences like Oncology 2026 provide a valuable platform for knowledge exchange and collaboration. The Allieva Pharma team interacted with oncologists, healthcare providers, and industry leaders to discuss the latest advancements in oncology research, cancer treatment innovations, and patient care strategies.
These discussions help strengthen partnerships within the medical community and contribute to improving cancer treatment accessibility.
Cancer continues to be one of the major global health challenges. Through continuous innovation and collaboration, Allieva Pharma is committed to delivering high-quality oncology medicines that are accessible and affordable for patients worldwide.
By participating in Oncology 2026, the company reaffirmed its dedication to supporting healthcare professionals and improving outcomes for cancer patients.
Allieva Pharma will continue expanding its oncology product portfolio and contributing to global efforts aimed at advancing cancer treatment and patient care.
